Insider · CIK 0001376043

Coughlin Timothy

CIK 0001376043 Name as filed on the most recent filing

Filed as Coughlin Timothy (3)· Coughlin Timothy (2)· Coughlin Timothy P (31)

52 transaction lines · from 36 filings · filed 2008-02-14 to 2026-06-16 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

52 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2026-06-12 S, Open-market sale Travere Therapeutics, Inc.TVTX 500,747, disposed Open Form 4 filing 0001376043-26-000010
2026-05-15 S, Open-market sale Travere Therapeutics, Inc.TVTX 141,343, disposed Open Form 4 filing 0001376043-26-000005
2025-10-31 S, Open-market sale Travere Therapeutics, Inc.TVTX 630,601, disposed Open Form 4 filing 0001376043-25-000004
2024-05-30 P, Open-market purchase aTYR Pharma IncLIFE 87,500, acquired Open Form 4 filing 0000950170-24-067989
2022-06-03 S, Open-market sale Fate Therapeutics IncFATE 32,824, disposed Open Form 4 filing 0001209191-22-034541
2017-02-06 S, Open-market sale Neurocrine Biosciences IncNBIX 41,544, disposed Open Form 4 filing 0001209191-17-008909
2017-02-03 S, Open-market sale Neurocrine Biosciences IncNBIX 63,825, disposed Open Form 4 filing 0001209191-17-008136
2017-01-17 S, Open-market sale Neurocrine Biosciences IncNBIX 71,138, disposed Open Form 4 filing 0001209191-17-004305
2017-01-10 S, Open-market sale Neurocrine Biosciences IncNBIX 75,898, disposed Open Form 4 filing 0001209191-17-003584
2016-11-23 P, Open-market purchase Fate Therapeutics IncFATE 149,997, acquired Open Form 4 filing 0001209191-16-152153
2016-02-03 S, Open-market sale Neurocrine Biosciences IncNBIX 57,090, disposed Open Form 4 filing 0001209191-16-095848
2016-01-19 S, Open-market sale Neurocrine Biosciences IncNBIX 81,708, disposed Open Form 4 filing 0001209191-16-092884
2016-01-11 S, Open-market sale Neurocrine Biosciences IncNBIX 77,438, disposed Open Form 4 filing 0001209191-16-091250
2015-10-16 S, Open-market sale Neurocrine Biosciences IncNBIX 1,194,500, disposed Open Form 4 filing 0001209191-15-076197
2015-07-20 S, Open-market sale Neurocrine Biosciences IncNBIX 1,100,000, disposed Open Form 4 filing 0001209191-15-061949
2015-07-13 S, Open-market sale Neurocrine Biosciences IncNBIX 1,000,000, disposed Open Form 4 filing 0001209191-15-060833
2015-06-08 S, Open-market sale Neurocrine Biosciences IncNBIX 2,704,800, disposed Open Form 4 filing 0001209191-15-051964
2015-03-20 S, Open-market sale Neurocrine Biosciences IncNBIX 1,779,600, disposed Open Form 4 filing 0001209191-15-028992
2015-01-16 S, Open-market sale Neurocrine Biosciences IncNBIX 53,918, disposed Open Form 4 filing 0000914475-15-000049
2015-01-12 S, Open-market sale Neurocrine Biosciences IncNBIX 49,648, disposed Open Form 4 filing 0000914475-15-000033
2015-01-08 S, Open-market sale Neurocrine Biosciences IncNBIX 272,500, disposed Open Form 4 filing 0000914475-15-000016
2014-12-19 S, Open-market sale Neurocrine Biosciences IncNBIX 240,200, disposed Open Form 4 filing 0001209191-14-077169
2014-12-18 S, Open-market sale Neurocrine Biosciences IncNBIX 2 lines 463,600, disposed Open Form 4 filing 0001209191-14-077169
2014-12-10 S, Open-market sale Neurocrine Biosciences IncNBIX 2 lines 429,500, disposed Open Form 4 filing 0000914475-14-000081
2014-11-28 S, Open-market sale Neurocrine Biosciences IncNBIX 201,400, disposed Open Form 4 filing 0001209191-14-072294
2014-10-31 S, Open-market sale Neurocrine Biosciences IncNBIX 190,000, disposed Open Form 4 filing 0000914475-14-000066
2014-10-30 S, Open-market sale Neurocrine Biosciences IncNBIX 186,200, disposed Open Form 4 filing 0000914475-14-000064
2014-10-28 S, Open-market sale Neurocrine Biosciences IncNBIX 180,000, disposed Open Form 4 filing 0000914475-14-000064
2014-01-10 S, Open-market sale Neurocrine Biosciences IncNBIX 32,480, disposed Open Form 4 filing 0000914475-14-000021
2014-01-07 S, Open-market sale Neurocrine Biosciences IncNBIX 1,172,500, disposed Open Form 4 filing 0000914475-14-000009
2013-08-21 S, Open-market sale Neurocrine Biosciences IncNBIX 286,477, disposed Open Form 4 filing 0000914475-13-000071
2013-08-05 S, Open-market sale Neurocrine Biosciences IncNBIX 164,365, disposed Open Form 4 filing 0000914475-13-000064
2011-02-28 S, Open-market sale Neurocrine Biosciences IncNBIX 84,104, disposed Open Form 4 filing 0000914475-11-000011
2010-03-01 S, Open-market sale Neurocrine Biosciences IncNBIX 31,972, disposed Open Form 4 filing 0000914475-10-000027
2010-01-12 S, Open-market sale Neurocrine Biosciences IncNBIX 21,951, disposed Open Form 4 filing 0000914475-10-000010
2009-03-30 S, Open-market sale Neurocrine Biosciences IncNBIX 41,537, disposed Open Form 4 filing 0000914475-09-000027
2009-01-13 S, Open-market sale Neurocrine Biosciences IncNBIX 28,648, disposed Open Form 4 filing 0000914475-09-000016
2008-02-12 S, Open-market sale Neurocrine Biosciences IncNBIX 7,000, disposed Open Form 4 filing 0000914475-08-000016
2008-02-12 S, Open-market sale Neurocrine Biosciences IncNBIX 5,544, disposed Open Form 4 filing 0000914475-08-000016
2008-02-12 S, Open-market sale Neurocrine Biosciences IncNBIX 5,050, disposed Open Form 4 filing 0000914475-08-000016
2008-02-12 S, Open-market sale Neurocrine Biosciences IncNBIX 4,980, disposed Open Form 4 filing 0000914475-08-000016
2008-02-12 S, Open-market sale Neurocrine Biosciences IncNBIX 3,514, disposed Open Form 4 filing 0000914475-08-000016
2008-02-12 S, Open-market sale Neurocrine Biosciences IncNBIX 2,032, disposed Open Form 4 filing 0000914475-08-000016
2008-02-12 S, Open-market sale Neurocrine Biosciences IncNBIX 1,996, disposed Open Form 4 filing 0000914475-08-000016
2008-02-12 S, Open-market sale Neurocrine Biosciences IncNBIX 1,984, disposed Open Form 4 filing 0000914475-08-000016
2008-02-12 S, Open-market sale Neurocrine Biosciences IncNBIX 1,774, disposed Open Form 4 filing 0000914475-08-000016
2008-02-12 S, Open-market sale Neurocrine Biosciences IncNBIX 1,530, disposed Open Form 4 filing 0000914475-08-000016
2008-02-12 S, Open-market sale Neurocrine Biosciences IncNBIX 1,509, disposed Open Form 4 filing 0000914475-08-000016

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase
Relationships on this page
D, Director
Director
O, Officer
Officer

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 2
  • Open-market sale 50
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Coughlin Timothy, insider transactions. Retrieved 2026-08-24 from https://ebomi.com/insider/0001376043

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.